Kiniksa Pharmaceuticals International, Plc Q3 2026 Earnings Preview

Kiniksa Pharmaceuticals International, plc (KNSA) is scheduled to announce Q3 earnings results on Tuesday, October 27th, before market open. - The consensus EPS Estimate is $0.31 (+34.8% Y/Y) and the consensus Revenue Estimate is $260.61M (+44.1% Y/Y). - Over the last 1

Kiniksa Pharmaceuticals International, plc (KNSA) is scheduled to announce Q3 earnings results on Tuesday, October 27th, before market open. – The consensus EPS Estimate is $0.31 (+34.8% Y/Y) and the consensus Revenue Estimate is $260.61M (+44.1% Y/Y). – Over the last 1

Leave a Reply

Your email address will not be published. Required fields are marked *